VESANOID
10mgVESANOID10mg
VESANOID (Tretinoin/ATRA) 10mg capsules by Roche — differentiation therapy for acute promyelocytic leukemia (APL). ATRA+ATO: 97% CR, 90%+ cure rate.
Key Benefits
- 97% complete remission with ATRA+ATO protocol
- 90%+ long-term cure rate — most curable AML subtype
- Differentiation therapy — unique mechanism of action
- Oral capsules — convenient administration
- Room temperature storage — no cold chain needed
- Emergency supply available for urgent APL cases
Contact Us for Pricing
Get a written quote against a prescription within 24 hours for VESANOID 10mg. Our team is available 24/7.
Direct line: +44 7429 917553
Prescription required
We do not proceed without one
Licensed Türkiye channels
İTS serial-traceable by karekod
Delivered in person
Not shipped by courier
Written reply
Quote within 24 hours
How VESANOID Works
Tretinoin (ATRA) induces terminal differentiation of leukemic promyelocytes by degrading the PML-RARα fusion oncoprotein caused by t(15;17) translocation. This releases the block on myeloid differentiation, forcing immature cancer cells to mature into functional granulocytes.
About VESANOID 10mg
VESANOID (Tretinoin/All-Trans Retinoic Acid) 10mg capsules by Roche is the revolutionary differentiation therapy that transformed acute promyelocytic leukemia (APL) from 75% fatal to 90%+ curable. Unlike conventional chemotherapy, ATRA forces leukemic promyelocytes to differentiate into mature granulocytes by degrading the PML-RARα fusion oncoprotein. The ATRA+ATO (arsenic trioxide) protocol achieves 97% complete remission and 99% overall survival at 50 months — making APL the most curable form of acute myeloid leukemia, without conventional chemotherapy. Working through licensed Turkish pharmacy channels, we maintain emergency stock of Vesanoid for urgent APL supply with express shipping worldwide.
Common Uses
- Acute promyelocytic leukemia (APL/AML-M3) — induction therapy
- APL with t(15;17) translocation / PML-RARα fusion
- ATRA+ATO protocol (low/intermediate-risk APL)
- ATRA+chemotherapy (high-risk APL)
Dosage Information
Adults: 45mg/m²/day orally in 2 divided doses. Children: 25mg/m²/day. Continue until CR or maximum 90 days. Take with food.
Always consult with a qualified healthcare professional for proper dosing. This information is for reference only.
Storage & Handling
Store at 15-25°C (59-77°F). Protect from light and heat. Keep in original packaging. No refrigeration required.
We ensure proper cold chain handling during shipping to maintain product integrity.
Full prescribing monograph
A single reference page compiled from the manufacturer's prescribing information and the regulator's public product data. No pricing is published on it.
Frequently Asked Questions About VESANOID
Find answers to common questions about ordering, pricing, and shipping.
Related Oncology Medications Products
Explore more oncology medications medications from our catalog
